PMC Articles for MedGen (Select 274089) - PMC

Links from MedGen

Items: 1 to 20 of 23

<< First< Prev

Page of 2

Select item 100674341.

BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance

Yaguang Luo, Shinya Akatsuka, Yashiro Motooka, Yingyi Kong, Hao Zheng, Tomoji Mashimo, Tatsuhiko Imaoka, Shinya Toyokuni

Cancer Sci. 2023 Apr; 114(4): 1423–1436. Published online 2023 Feb 2. doi: 10.1111/cas.15705

PMCID:: PMC10067434

Article PDF–59M

Select item 97859402.

BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents

Sourat Darabi, David R. Braxton, Joanne Xiu, Benedito A. Carneiro, Jeff Swensen, Emmanuel S. Antonarakis, Stephen V. Liu, Rana R. McKay, David Spetzler, Wafik S. El-Deiry, Michael J. Demeure

Medicina (Kaunas) 2022 Dec; 58(12): 1818. Published online 2022 Dec 10. doi: 10.3390/medicina58121818

PMCID:: PMC9785940

Article PDF–969K

Select item 95765933.

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

Rihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, Michelandrea De Cesare, Gennaro Colella, Matteo Dugo, Silvia Veneroni, Valentina Doldi, Silvia Martini, Dario Baratti, Shigeki Kusamura, Paolo Verderio, Marcello Deraco, Paolo Gandellini, Nadia Zaffaroni, Valentina Zuco

Cancer Gene Ther. 2022; 29(10): 1394–1404. Published online 2022 Mar 29. doi: 10.1038/s41417-022-00460-7

PMCID:: PMC9576593

Article PDF–2.4M

Select item 85190724.

Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas

Kenzo Hiroshima, Di Wu, Eitetsu Koh, Yasuo Sekine, Daisuke Ozaki, Toshikazu Yusa, Tadao Nakazawa, Shoutaro Tsuji, Yohei Miyagi, Ann E. Walts, Alberto M. Marchevsky, Aliya N. Husain, Kohzoh Imai

Pathol Int. 2021 Sep; 71(9): 604–613. Published online 2021 Jul 9. doi: 10.1111/pin.13140

PMCID:: PMC8519072

Article PDF–2.9M

Select item 68388755.

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Andrew R. Haas, Janos L. Tanyi, Mark H. O’Hara, Whitney L. Gladney, Simon F. Lacey, Drew A. Torigian, Michael C. Soulen, Lifeng Tian, Maureen McGarvey, Anne Marie Nelson, Caitlin S. Farabaugh, Edmund Moon, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June, Steven M. Albelda, Gregory L. Beatty

Mol Ther. 2019 Nov 6; 27(11): 1919–1929. Published online 2019 Jul 30. doi: 10.1016/j.ymthe.2019.07.015

PMCID:: PMC6838875

Article PDF–1.4M

Select item 65001426.

Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy

Raffit Hassan, Betsy Morrow, Anish Thomas, Tom Walsh, Ming K. Lee, Suleyman Gulsuner, Meghana Gadiraju, Vasiliki Panou, Shaojian Gao, Idrees Mian, Javed Khan, Mark Raffeld, Snehal Patel, Liqiang Xi, Jun S. Wei, Mary Hesdorffer, Jingli Zhang, Kathleen Calzone, Arpita Desai, Emerson Padiernos, Christine Alewine, David S. Schrump, Seth M. Steinberg, Hedy L. Kindler, Mary-Claire King, Jane E. Churpek

Proc Natl Acad Sci U S A. 2019 Apr 30; 116(18): 9008–9013. Published online 2019 Apr 11. doi: 10.1073/pnas.1821510116

PMCID:: PMC6500142

Article PDF–702K

Select item 57457277.

SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma

Yuen Yee Cheng, Ellie Mok, Sarah Tan, Catherine Leygo, Chris McLaughlin, A. M. George, Glen Reid

Dis Markers. 2017; 2017: 2536187. Published online 2017 Dec 13. doi: 10.1155/2017/2536187

PMCID:: PMC5745727

Article PDF–4.8M

Select item 56305048.

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell, Evanthia Galanis

Curr Cancer Drug Targets. Author manuscript; available in PMC 2019 Jan 1.

Published in final edited form as: Curr Cancer Drug Targets. 2018; 18(2): 177–187. doi: 10.2174/1568009617666170222125035

PMCID:: PMC5630504

Article PDF–349K

Select item 56087779.

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Gayathri Srinivasan, Gurjit Singh Sidhu, Elizabeth A. Williamson, Aruna S. Jaiswal, Nasreen Najmunnisa, Keith Wilcoxen, Dennie Jones, Thomas J. George, Jr., Robert Hromas

Cancer Chemother Pharmacol. 2017; 80(4): 861–867. Published online 2017 Jul 29. doi: 10.1007/s00280-017-3401-y

PMCID:: PMC5608777

Article PDF–567K

Select item 543229410.

Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma

Shingo Inaguma, Zengfeng Wang, Jerzy Lasota, Masanori Onda, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat, Hiroshi Ikeda, David S. Schrump, Raffit Hassan, Ira Pastan, Markku Miettinen

Oncotarget. 2017 Apr 18; 8(16): 26744–26754. Published online 2017 Mar 1. doi: 10.18632/oncotarget.15814

PMCID:: PMC5432294

Article PDF–4.5M

Select item 487341411.

Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations

Yuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, Jianming Pei, Eleonora Sementino, Craig W. Menges, Kathy Q. Cai, Frank J. Rauscher, Andres J. Klein-Szanto, Joseph R. Testa

Cancer Res. Author manuscript; available in PMC 2017 May 1.

Published in final edited form as: Cancer Res. 2016 May 1; 76(9): 2836–2844. Published online 2016 Feb 19. doi: 10.1158/0008-5472.CAN-15-3371

PMCID:: PMC4873414

Article PDF–3.5M

Select item 431246212.

Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome

Angel Chao, Chyong-Huey Lai, Yun-Shien Lee, Shir-Hwa Ueng, Chiao-Yun Lin, Tzu-Hao Wang

BMC Cancer. 2015; 15: 8. Published online 2015 Jan 15. doi: 10.1186/s12885-015-1010-x

PMCID:: PMC4312462

Article PDF–881K

Select item 409073013.

Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples

M J Patterson, R E Sutton, I Forrest, R Sharrock, M Lane, A Kaufmann, R O'Donnell, R J Edmondson, B T Wilson, N J Curtin

Br J Cancer. 2014 Jul 1; 111(1): 94–100. Published online 2014 May 27. doi: 10.1038/bjc.2014.261

PMCID:: PMC4090730

Article PDF–981K

Select item 389754314.

MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma

Ombretta Melaiu, Justin Stebbing, Ylenia Lombardo, Elisa Bracci, Norihisa Uehara, Alessandra Bonotti, Alfonso Cristaudo, Rudy Foddis, Luciano Mutti, Roberto Barale, Federica Gemignani, Georgios Giamas, Stefano Landi

PLoS One. 2014; 9(1): e85935. Published online 2014 Jan 21. doi: 10.1371/journal.pone.0085935

Correction in:: PLoS One. 2017; 12(6): e0180317.

PMCID:: PMC3897543

Article PDF–853K

Select item 382995915.

Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice

Heungnam Kim, Wei Gao, Mitchell Ho

PLoS One. 2013; 8(11): e81919. Published online 2013 Nov 15. doi: 10.1371/journal.pone.0081919

PMCID:: PMC3829959

Article PDF–1.1M

Select item 322540316.

PINCH-2 expression in cancers involving serosal effusions using quantitative PCR

Y. Yuan, H. P. Dong, D. A. Nymoen, J. M. Nesland, C. Wu, B. Davidson

Cytopathology. Author manuscript; available in PMC 2012 Feb 1.

Published in final edited form as: Cytopathology. 2011 Feb; 22(1): 22–29. doi: 10.1111/j.1365-2303.2010.00757.x

PMCID:: PMC3225403

Article PDF–1.0M

Select item 286253217.

A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions

Daniel H Sterman, Adri Recio, Andrew R Haas, Anil Vachani, Sharyn I Katz, Colin T Gillespie, Guanjun Cheng, Jing Sun, Edmund Moon, Luana Pereira, Xinzhong Wang, Daniel F Heitjan, Leslie Litzky, Carl H June, Robert H Vonderheide, Richard G Carroll, Steven M Albelda

Mol Ther. 2010 Apr; 18(4): 852–860. Published online 2010 Jan 12. doi: 10.1038/mt.2009.309

PMCID:: PMC2862532

Article PDF–354K

Select item 278399418.

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

Yuan Yuan, Dag André Nymoen, Helene Tuft Stavnes, Anne Katrine Rossnes, Ola Bjørang, Chuanyue Wu, Jahn M. Nesland, Ben Davidson

Am J Surg Pathol. Author manuscript; available in PMC 2010 Nov 1.

Published in final edited form as: Am J Surg Pathol. 2009 Nov; 33(11): 1673–1682. doi: 10.1097/PAS.0b013e3181b6bde3

PMCID:: PMC2783994

Article PDF–2.4M

Select item 263504519.

A Binding Domain on Mesothelin for CA125/MUC16

Osamu Kaneko, Lucy Gong, Jingli Zhang, Johanna K. Hansen, Raffit Hassan, Byungkook Lee, Mitchell Ho

J Biol Chem. 2009 Feb 6; 284(6): 3739–3749. doi: 10.1074/jbc.M806776200

PMCID:: PMC2635045

Article PDF–834K

Select item 113698920.

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Gennadi V. Glinsky, Olga Berezovska, Anna B. Glinskii

J Clin Invest. 2005 Jun 1; 115(6): 1503–1521. doi: 10.1172/JCI23412

PMCID:: PMC1136989

Article PDF–1.5M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 23

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity